DESIGN THERAPEUTICS INC (DSGN) Stock Balance Sheet
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 21.20M | 26.50M | 298.60M | 2.40M | 100.00K | |||
| Marketable Securities | 260.60M | 303.90M | 85.50M | 33.70M | 0.00 | |||
| Receivables | 1.43M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.35M | 4.70M | 1.40M | 100.00K | 0.00 | |||
| Total Current Assets | 284.58M | 335.10M | 385.40M | 36.20M | 100.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.63M | 5.60M | 5.10M | 100.00K | 0.00 | |||
| Other Non-Current Assets | 430.00K | 500.00K | 0.00 | 200.00K | 0.00 | |||
| Total Non-Current Assets | 5.06M | 6.00M | 5.20M | 300.00K | 0.00 | |||
| TOTAL ASSETS | 289.64M | 341.10M | 390.60M | 36.50M | 100.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 700.00K | |||
| Accrued Expenses | 7.68M | 7.80M | 3.70M | 900.00K | 200.00K | |||
| Accounts Payable | 1.94M | 3.00M | 1.60M | 1.40M | 2.50M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 300.00K | |||
| Total Current Liabilities | 9.62M | 10.80M | 5.30M | 2.30M | 3.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.33M | 3.10M | 3.10M | 100.00K | 0.00 | |||
| Total Non-Current Liabilities | 2.33M | 3.00M | 3.10M | 200.00K | 0.00 | |||
| TOTAL LIABILITIES | 11.96M | 13.80M | 8.40M | 2.50M | 3.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -177.63M | -110.80M | -47.50M | -11.90M | -3.60M | |||
| Additional Paid In Capital | 455.25M | 441.40M | 429.80M | 500.00K | 0.00 | |||
| Common Shares | 6.00K | 0.00 | 0.00 | 45.40M | 0.00 | |||
| Other Shareholders' Equity | 62.00K | -3.40M | -200.00K | 200.00K | 0.00 | |||
| Shares Outstanding | 56.47M | 55.90M | 55.40M | 53.80M | 53.80M | |||
| Tangible Book Value per Share | 4.92 | 5.86 | 6.90 | -0.21 | -0.07 | |||
| Total Shareholders' Equity | 277.69M | 327.30M | 382.10M | 34.00M | -3.60M | |||
| TOTAL LIABILITIES AND EQUITY | 289.64M | 341.10M | 390.60M | 36.50M | 100.00K | |||
| Statistics | ||||||||
| Current Ratio | 29.58 | 31.03 | 72.72 | 15.74 | 0.03 | |||
| Return On Assets (ROA) | -23.08% | -18.56% | -9.10% | -22.68% | -2050.00% | |||
| Return On Equity (ROE) | -24.08% | -19.34% | -9.30% | -24.35% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21